158 related articles for article (PubMed ID: 26365732)
1. [Management of invasive candidiasis in non-neutropenic patient].
Cardozo C; Mensa J
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():34-7. PubMed ID: 26365732
[TBL] [Abstract][Full Text] [Related]
2. Echinocandins in the treatment of candidaemia and invasive candidiasis: clinical and economic perspectives.
Neoh CF; Slavin M; Chen SC; Stewart K; Kong DC
Int J Antimicrob Agents; 2014 Mar; 43(3):207-14. PubMed ID: 24670423
[TBL] [Abstract][Full Text] [Related]
3. EPICO PROJECT. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non- neutropenic critically ill adult patients.
Epico Project Group
Rev Esp Quimioter; 2013 Jun; 26(2):131-50. PubMed ID: 23817652
[TBL] [Abstract][Full Text] [Related]
4. Treatment of invasive candidiasis in neutropenic patients: systematic review of randomized controlled treatment trials.
Kanji JN; Laverdière M; Rotstein C; Walsh TJ; Shah PS; Haider S
Leuk Lymphoma; 2013 Jul; 54(7):1479-87. PubMed ID: 23113686
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of echinocandins and nonechinocandins for the treatment of Candida parapsilosis Infections: a meta-analysis.
Kale-Pradhan PB; Morgan G; Wilhelm SM; Johnson LB
Pharmacotherapy; 2010 Dec; 30(12):1207-13. PubMed ID: 21114387
[TBL] [Abstract][Full Text] [Related]
6. Treatment of invasive candidiasis: between guidelines and daily clinical practice.
Tagliaferri E; Menichetti F
Expert Rev Anti Infect Ther; 2015 Jun; 13(6):685-9. PubMed ID: 25818660
[TBL] [Abstract][Full Text] [Related]
7. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
[TBL] [Abstract][Full Text] [Related]
8. Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.
Bailly S; Leroy O; Montravers P; Constantin JM; Dupont H; Guillemot D; Lortholary O; Mira JP; Perrigault PF; Gangneux JP; Azoulay E; Timsit JF
Intensive Care Med; 2015 Nov; 41(11):1931-40. PubMed ID: 26370688
[TBL] [Abstract][Full Text] [Related]
9. Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: A post-hoc causal inference model using the AmarCAND2 study.
Bailly S; Leroy O; Azoulay E; Montravers P; Constantin JM; Dupont H; Guillemot D; Lortholary O; Mira JP; Perrigault PF; Gangneux JP; Timsit JF;
J Infect; 2017 Apr; 74(4):408-417. PubMed ID: 28104387
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
[TBL] [Abstract][Full Text] [Related]
11. [Épico project: Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients. Grupo Proyecto Épico].
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Iberoam Micol; 2013; 30(3 Suppl 1):135-49. PubMed ID: 23764554
[TBL] [Abstract][Full Text] [Related]
12. Invasive candidiasis in the neutropenic patient.
Fortún J; Gioia F
Rev Esp Quimioter; 2017 Sep; 30 Suppl 1():22-25. PubMed ID: 28882010
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials.
Chen Q; Lin MH; Chen ML; Liu ZY; Chai D; Wang R
Chin Med J (Engl); 2012 Jan; 125(2):345-51. PubMed ID: 22340571
[TBL] [Abstract][Full Text] [Related]
14. EPICO 2.0 PROJECT. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodríguez A;
Rev Esp Quimioter; 2014 Sep; 27(3):196-212. PubMed ID: 25229375
[TBL] [Abstract][Full Text] [Related]
15. Invasive Candidiasis.
Gonzalez-Lara MF; Ostrosky-Zeichner L
Semin Respir Crit Care Med; 2020 Feb; 41(1):3-12. PubMed ID: 32000280
[TBL] [Abstract][Full Text] [Related]
16. Candida tropicalis in human disease.
Chai LY; Denning DW; Warn P
Crit Rev Microbiol; 2010 Nov; 36(4):282-98. PubMed ID: 20883082
[TBL] [Abstract][Full Text] [Related]
17. Anidulafungin: is it a promising option in the treatment of pediatric invasive fungal infections?
Tapısız A
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):339-46. PubMed ID: 21417873
[TBL] [Abstract][Full Text] [Related]
18. Invasive Candidiasis.
McCarty TP; Pappas PG
Infect Dis Clin North Am; 2016 Mar; 30(1):103-24. PubMed ID: 26739610
[TBL] [Abstract][Full Text] [Related]
19. Management of invasive Candida infections in non-neutropenic critically ill patients: from prophylaxis to early therapy.
Garnacho-Montero J; Díaz-Martín A; Cayuela-Dominguez A
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S137-41. PubMed ID: 19013338
[TBL] [Abstract][Full Text] [Related]
20. Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis.
Miyazaki T; Kohno S
Expert Rev Anti Infect Ther; 2015; 13(9):1171-83. PubMed ID: 26089168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
